These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 17854036)

  • 21. Natural 30 base pair and 69 base pair deletion variants of the LMP1 oncogene do stimulate NF-kappaB-mediated transcription.
    Rothenberger S; Bachmann E; Berger C; McQuain C; Odermatt BF; Knecht H
    Oncogene; 1997 May; 14(17):2123-6. PubMed ID: 9160892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Detection of C-terminal 30 bp-deletion mutation of latent membrane protein 1 of EBV in childhood lymphoma].
    Xie ZD; Zhou CJ; Wang L; Shen KL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Dec; 22(6):464-7. PubMed ID: 19544647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Deletion of Epstein-Barr virus latent membrane protein 1 gene in United States and Brazilian Hodgkin's disease and reactive lymphoid tissue: high frequency of a 30-bp deletion.
    Hayashi K; Chen WG; Chen YY; Bacchi MM; Bacchi CE; Alvarenga M; Abreu ES; Chang KL; Weiss LM
    Hum Pathol; 1997 Dec; 28(12):1408-14. PubMed ID: 9416698
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Mutations of the Epstein-Barr virus LMP1 gene mutations in Russian patients with lymphoid pathology and healthy individuals].
    Pavlish OA; Diduk SV; Smirnova KV; Shcherbak LN; Goncharova EV; Shalginskikh NA; Arkhipov VV; Kichigina MIu; Stepina VN; Belousova NV; Osmanov EA; Iakovleva LS; Gurtsevich VE
    Vopr Virusol; 2008; 53(1):10-6. PubMed ID: 18318128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationships between Epstein-Barr virus latent membrane protein 1 and regulatory T cells in Hodgkin's lymphoma.
    Marshall NA; Culligan DJ; Tighe J; Johnston PW; Barker RN; Vickers MA
    Exp Hematol; 2007 Apr; 35(4):596-604. PubMed ID: 17379070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Restricted low-level human antibody responses against Epstein-Barr virus (EBV)-encoded latent membrane protein 1 in a subgroup of patients with EBV-associated diseases.
    Meij P; Vervoort MB; Aarbiou J; van Dissel P; Brink A; Bloemena E; Meijer CJ; Middeldorp JM
    J Infect Dis; 1999 May; 179(5):1108-15. PubMed ID: 10191211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of Epstein-Barr virus status on clinical outcome in Hodgkin's lymphoma.
    Kwon JM; Park YH; Kang JH; Kim K; Ko YH; Ryoo BY; Lee SS; Lee SI; Koo HH; Kim WS
    Ann Hematol; 2006 Jul; 85(7):463-8. PubMed ID: 16534596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Sequence analysis of the deletion and mutation in carboxy terminal region of the Epstein-Barr virus latent membrane protein 1 derived from nasopharyngeal carcinoma patients].
    Tang MZ; Zheng YM; Guo XC; Zhang YL; Zeng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Mar; 17(1):35-8. PubMed ID: 12870015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus (EBV) latent membrane protein-1-specific cytotoxic T lymphocytes targeting EBV-carrying natural killer cell malignancies.
    Demachi-Okamura A; Ito Y; Akatsuka Y; Tsujimura K; Morishima Y; Takahashi T; Kuzushima K
    Eur J Immunol; 2006 Mar; 36(3):593-602. PubMed ID: 16479544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma.
    Gulley ML; Glaser SL; Craig FE; Borowitz M; Mann RB; Shema SJ; Ambinder RF
    Am J Clin Pathol; 2002 Feb; 117(2):259-67. PubMed ID: 11863222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein-Barr virus-associated nuclear antigen-1 carboxy-terminal gene sequences in Japanese and American patients with gastric carcinoma.
    Chen YY; Chang KL; Chen WG; Shibata D; Hayashi K; Weiss LM
    Lab Invest; 1998 Jul; 78(7):877-82. PubMed ID: 9690565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Frequent expression of the tumor necrosis factor receptor-associated factor 1 in latent membrane protein 1-positive posttransplant lymphoproliferative disease and HIV-associated lymphomas.
    Murray PG; Swinnen LJ; Flavell JR; Ragni MV; Baumforth KR; Toomey SM; Filipovich AH; Lowe D; Schnell CS; Johl J; Gulley M; Young LS; Ambinder RF
    Hum Pathol; 2001 Sep; 32(9):963-9. PubMed ID: 11567226
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
    Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
    Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of Epstein-Barr virus Type I variants based on linked polymorphism among EBNA3A, -3B, and -3C genes.
    Görzer I; Niesters HG; Cornelissen JJ; Puchhammer-Stöckl E
    Virus Res; 2006 Jun; 118(1-2):105-14. PubMed ID: 16406167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epstein-Barr virus (EBV) variant with a 30-bp deletion at the carboxyl terminus (amino acids 346-355) of latent membrane protein-1 (LMP1) gene is able to transform cells and evade immune surveillance.
    Tao Q; Ambinder RF; Swinnen LJ
    Am J Pathol; 1998 May; 152(5):1398-9. PubMed ID: 9588909
    [No Abstract]   [Full Text] [Related]  

  • 36. Clonality analysis by sequence variation of the latent membrane protein 1 gene in patients with chronic active Epstein-Barr virus infection.
    Shibata Y; Hoshino Y; Hara S; Yagasaki H; Kojima S; Nishiyama Y; Morishima T; Kimura H
    J Med Virol; 2006 Jun; 78(6):770-9. PubMed ID: 16628581
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coexpression of major histocompatibility complex class I and LMP1 in Epstein-Barr virus-positive Hodgkin's lymphoma in a pediatric age group.
    Aybar A; Krause JR
    Microsc Res Tech; 2005 Nov; 68(3-4):247-9. PubMed ID: 16276512
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells.
    Liu MT; Chen YR; Chen SC; Hu CY; Lin CS; Chang YT; Wang WB; Chen JY
    Oncogene; 2004 Apr; 23(14):2531-9. PubMed ID: 14716302
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr viral infection in extranodal lymphoma of the head and neck: correlation with prognosis and response to treatment.
    Bahnassy AA; Zekri AR; Asaad N; El-Houssini S; Khalid HM; Sedky LM; Mokhtar NM
    Histopathology; 2006 Apr; 48(5):516-28. PubMed ID: 16623777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Hodgkin's disease Reed-Sternberg cells and normal B-lymphocytes are infected by related Epstein-Barr virus strains.
    Faumont N; Trempat P; Brousset P; Delsol G; Meggetto F
    Virus Res; 2004 May; 101(2):163-73. PubMed ID: 15041184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.